Ablation of NLRP3 inflammasome attenuates muscle atrophy via inhibiting pyroptosis, proteolysis and apoptosis following denervation
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 13 (1) , 374-390
Abstract
Rationale: The inflammasome has been widely reported to be involved in various myopathies, but little is known about its role in denervated muscle. Here, we explored the role of NLRP3 inflammasome activation in experimental models of denervation in vitro and in vivo.Keywords
This publication has 39 references indexed in Scilit:
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell deathNature, 2015
- Muscle wasting in disease: molecular mechanisms and promising therapiesNature Reviews Drug Discovery, 2014
- Interleukin-1 stimulates catabolism in C2C12 myotubesAmerican Journal of Physiology-Cell Physiology, 2009
- Phosphodiesterase 4 inhibition reduces skeletal muscle atrophyMuscle & Nerve, 2005
- Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophyNeuromuscular Disorders, 2005
- The InflammasomeMolecular Cell, 2002
- Skeletal muscle hypertrophy and anti‐atrophy effects of clenbuterol are mediated by the β2‐adrenergic receptorMuscle & Nerve, 2002
- Identification of Ubiquitin Ligases Required for Skeletal Muscle AtrophyScience, 2001
- A prospective, quantitative study on the clinical outcome of lingual nerve repairBritish Journal of Oral and Maxillofacial Surgery, 2000
- Different cytokines modulate ubiquitin gene expression in rat skeletal muscleCancer Letters, 1998